28075-36-7

Upstream product

• 2816-57-1 2,6-dimethylcyclohexanone 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 

Downstream Products

• 65133-83-7 (+/-)-4t-(2,6-dimethyl-cyclohex-1-enyl)-but-3-en-2-one 
• 207915-72-8 (2E,4E,6E,8E)-9-(2,6-Dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-ol 
• 287944-08-5 2,6-dimethyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-cyclohexene 
• 1030239-95-2 C₁₆H₂₀O 
• 605-39-0 2,2'-dimethyl-1,1'-biphenyl 
• 1452823-83-4 1-((2,6-dimethylcyclohex-1-en-1-yl)methyl)-2-nitrobenzene 
• 854720-13-1 2,6-dimethylcyclohex-1-ene-1-carboxylic acid 
• 207915-73-9 (2E,4E,6E,8E)-9-(2,6-Dimethyl-cyclohex-1-enyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid methyl ester 
• 52152-27-9 1-demethylretinal 

Relevant academic research and scientific papers

Palladium-catalyzed decarboxylative vinylation of potassium nitrophenyl acetate: Application to the total synthesis of (±)-goniomitine

Merge and divert: The natural product (±)-goniomitine was synthesized by a method featuring two key steps: 1) fragment coupling to a functionalized cyclopentene by a novel palladium-catalyzed decarboxylative vinylation reaction and 2) an unprecedented one-pot integrated oxidation/reduction/cyclization (IORC) process to convert the substituted cyclopentene into the tetracyclic skeleton of goniomitine with high chemo-, regio-, and diastereoselectivity.

INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES

The present invention relates to compounds of formula (1) as claimed in claim 1, their use in the treatment or the prevention of viral disorders, including HIV. (Formula I)